5 Results for "

rhuMAb

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "rhuMAb" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P9984
CAS No.: 1044758-60-2
Synonyms: rhuMAb Beta7; RG7413; PRO145223

Target:  

Integrin

Research Areas:  

Cancer

Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9950
CAS No.: 242138-07-4
Synonyms: Olizumab; rhuMAb-E25; IGE25; RG-3648

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology Cancer

Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research . The component ratio of this product is Active ingredient : Excipients = 1:1.3-1:1.5.
loading...
    loading...
Cat. No.: HY-P99286
CAS No.: 912628-39-8
Synonyms: PRO 95780; rhuMAb-DR 5; Anti-Human DR5 Recombinant Antibody

Target:  

Apoptosis

Research Areas:  

Cancer

Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .
loading...
    loading...
Cat. No.: HY-P99267
CAS No.: 948570-30-7
Synonyms: rhuMAb IFNalpha; Anti-Human IFN alpha Recombinant Antibody

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
loading...
    loading...
Cat. No.: HY-P99946
CAS No.: 211323-03-4
Synonyms: rhuMAb

Target:  

Integrin

Erlizumab (rhuMAb) is a monoclonal antibody against the Integrin b2/ITGB2/CD18 subunit of the Mac-1 receptor. Erlizumab can reduce reperfusion injury in myocardial infarction .
loading...
    loading...